Literature DB >> 30172227

Differentiating responders and non-responders to rTMS treatment for depression after one week using resting EEG connectivity measures.

N W Bailey1, K E Hoy2, N C Rogasch3, R H Thomson2, S McQueen2, D Elliot2, C M Sullivan2, B D Fulcher3, Z J Daskalakis4, P B Fitzgerald5.   

Abstract

BACKGROUND: Non-response to repetitive transcranial magnetic stimulation (rTMS) treatment for depression is costly for both patients and clinics. Simple and cheap methods to predict response would reduce this burden. Resting EEG measures differentiate responders from non-responders, so may have utility for response prediction.
METHODS: Fifty patients with treatment resistant depression and 21 controls had resting electroencephalography (EEG) recorded at baseline (BL). Patients underwent 5-8 weeks of rTMS treatment, with EEG recordings repeated at week 1 (W1). Forty-two participants had valid BL and W1 EEG data, and 12 were responders. Responders and non-responders were compared at BL and W1 in measures of theta (4-8 Hz) and alpha (8-13 Hz) power and connectivity, frontal theta cordance and alpha peak frequency. Control group comparisons were made for measures that differed between responders and non-responders. A machine learning algorithm assessed the potential to differentiate responders from non-responders using EEG measures in combination with change in depression scores from BL to W1.
RESULTS: Responders showed elevated theta connectivity across BL and W1. No other EEG measures differed between groups. Responders could be distinguished from non-responders with a mean sensitivity of 0.84 (p = 0.001) and specificity of 0.89 (p = 0.002) using cross-validated machine learning classification on the combination of all EEG and mood measures. LIMITATIONS: The low response rate limited our sample size to only 12 responders.
CONCLUSION: Resting theta connectivity at BL and W1 differ between responders and non-responders, and show potential for predicting response to rTMS treatment for depression.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Alpha; Electroencephalography; Theta; Transcranial magnetic stimulation; Treatment resistant depression

Mesh:

Year:  2018        PMID: 30172227     DOI: 10.1016/j.jad.2018.08.058

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  14 in total

1.  Identification of Clinical Features and Biomarkers that may inform a Personalized Approach to rTMS for Depression.

Authors:  Sarah L Garnaat; Andrew M Fukuda; Shiwen Yuan; Linda L Carpenter
Journal:  Pers Med Psychiatry       Date:  2019-10-18

Review 2.  Conducting double-blind placebo-controlled clinical trials of transcranial alternating current stimulation (tACS).

Authors:  Flavio Frohlich; Justin Riddle
Journal:  Transl Psychiatry       Date:  2021-05-12       Impact factor: 6.222

3.  Establishing Evidence for Clinical Utility of a Neuroimaging Biomarker in Major Depressive Disorder: Prospective Testing and Implementation Challenges.

Authors:  Mary E Kelley; Ki Sueng Choi; Justin K Rajendra; W Edward Craighead; Jeffrey J Rakofsky; Boadie W Dunlop; Helen S Mayberg
Journal:  Biol Psychiatry       Date:  2021-02-26       Impact factor: 12.810

Review 4.  Quantitative Electroencephalography in Guiding Treatment of Major Depression.

Authors:  Mark J Schiller
Journal:  Front Psychiatry       Date:  2019-01-23       Impact factor: 4.157

5.  Leveraging Machine Learning Approaches for Predicting Antidepressant Treatment Response Using Electroencephalography (EEG) and Clinical Data.

Authors:  Natalia Jaworska; Sara de la Salle; Mohamed-Hamza Ibrahim; Pierre Blier; Verner Knott
Journal:  Front Psychiatry       Date:  2019-01-14       Impact factor: 4.157

6.  Task-Modulated Brain Activity Predicts Antidepressant Responses of Prefrontal Repetitive Transcranial Magnetic Stimulation: A Randomized Sham-Control Study.

Authors:  Cheng-Ta Li; Chih-Ming Cheng; Chi-Hung Juan; Yi-Chun Tsai; Mu-Hong Chen; Ya-Mei Bai; Shih-Jen Tsai; Tung-Ping Su
Journal:  Chronic Stress (Thousand Oaks)       Date:  2021-04-08

7.  Efficacy of repetitive transcranial magnetic stimulation for improving lower limb function in individuals with neurological disorders: A systematic review and meta-analysis of randomized sham-controlled trials.

Authors:  Søren Krogh; Anette B Jønsson; Per Aagaard; Helge Kasch
Journal:  J Rehabil Med       Date:  2022-02-03       Impact factor: 2.912

8.  Resting-state and task-based centrality of dorsolateral prefrontal cortex predict resilience to 1 Hz repetitive transcranial magnetic stimulation.

Authors:  Sophie M D D Fitzsimmons; Linda Douw; Odile A van den Heuvel; Ysbrand D van der Werf; Chris Vriend
Journal:  Hum Brain Mapp       Date:  2020-05-12       Impact factor: 5.038

9.  Modulation of functional network properties in major depressive disorder following electroconvulsive therapy (ECT): a resting-state EEG analysis.

Authors:  Aron T Hill; Itay Hadas; Reza Zomorrodi; Daphne Voineskos; Faranak Farzan; Paul B Fitzgerald; Daniel M Blumberger; Zafiris J Daskalakis
Journal:  Sci Rep       Date:  2020-10-13       Impact factor: 4.379

10.  Conditioning to Enhance the Effects of Repetitive Transcranial Magnetic Stimulation on Experimental Pain in Healthy Volunteers.

Authors:  Léa Proulx-Bégin; Alberto Herrero Babiloni; Sabrina Bouferguene; Mathieu Roy; Gilles J Lavigne; Caroline Arbour; Louis De Beaumont
Journal:  Front Psychiatry       Date:  2022-02-22       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.